Specify a stock or a cryptocurrency in the search bar to get a summary
Silverback Therapeutics Inc
SPRYARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California. Address: 11682 El Camino Real, San Diego, CA, United States, 92130
Analytics
WallStreet Target Price
25.67 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SPRY
Dividend Analytics SPRY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SPRY
Stock Valuation SPRY
Financials SPRY
Results | 2019 | Dynamics |